Clinical trial / 2011
Flaxseed supplementation increased endostatin levels in normal human breast tissue in vivo without altering VEGF or angiogenin.
Researchers used microdialysis to sample extracellular proteins in normal breast tissue of women before and after six weeks of tamoxifen, six weeks of 25 g/day ground flaxseed, or in control women. Tamoxifen decreased VEGF and angiogenin levels and significantly increased endostatin. Flaxseed did not alter VEGF or angiogenin levels, but like tamoxifen, it significantly increased endostatin levels.
- Study type
- Intervention trial with control group
- Who was studied
- Women evaluated before and after tamoxifen, flaxseed, or control
- What was measured
- Extracellular VEGF, angiogenin, and endostatin levels in normal breast tissue
THE PAPER
Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.
Åberg UW, Saarinen N, Abrahamsson A, Nurmi T, Engblom S, Dabrosin C. PLoS One, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.